DePuy Spine, Inc. Acquires Minimally Invasive Spinal Portfolio Assets From The Bright Group, Inc 
10/19/2005 5:09:39 PM

RAYNHAM, Mass., Jan. 9 /PRNewswire-FirstCall/ -- DePuy Spine, Inc., a Johnson & Johnson company, reported today it has acquired certain assets of The Bright Group, Inc., a privately held medical device company. DePuy Spine plans to rapidly commercialize products for minimally invasive discectomy, lumbar spinal fusion, and cervical spinal fusion based upon platform technology obtained through this transaction. Terms of the transaction were not disclosed.

Bright's principal product, the INSITE(TM) System, is designed to provide less invasive access to the spinal disc, compared to medical techniques employed in traditional procedures. The INSITE(TM) product represents an advance for patients requiring discectomy and related procedures because its use can reduce the overall incision size and the impact of these surgeries on patients. It also enables minimally invasive spinal fixation.

"This strategic acquisition is a key component in DePuy Spine's commitment to establish a comprehensive minimally invasive spinal product portfolio," said Earl Fender, Worldwide President of DePuy Spine, Inc. "The technology will be used as a platform to develop innovative devices that will help to improve patient outcomes."

Robert Simonson, President of The Bright Group, Inc. said, "We are pleased DePuy Spine has recognized our efforts and success in the field of minimally invasive spine surgery."

The Bright Group, Inc., based in Boca Raton, Florida, is a research and development organization focused on developing technology for minimally invasive spinal surgery.

About DePuy Spine

DePuy Spine, a Johnson & Johnson company, has partnered with leading clinicians, researchers, and thought leaders to develop products to treat spine disorders for over 20 years. Today, DePuy Spine stands in the forefront of the worldwide spine market, with a substantial sales organization in the U.S. and an expanding worldwide distribution network. The company is committed to advancing the knowledge of all healthcare professionals and their patients in addressing spinal pathologies.

DePuy Spine, Inc.

CONTACT: Press, David Swearingen, +1-732-562-3132; or Investor, HelenShort, +1-732-524-6491, both for DePuy Spine, Inc.